BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 17157792)

  • 1. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
    Chin K; DeVries S; Fridlyand J; Spellman PT; Roydasgupta R; Kuo WL; Lapuk A; Neve RM; Qian Z; Ryder T; Chen F; Feiler H; Tokuyasu T; Kingsley C; Dairkee S; Meng Z; Chew K; Pinkel D; Jain A; Ljung BM; Esserman L; Albertson DG; Waldman FM; Gray JW
    Cancer Cell; 2006 Dec; 10(6):529-41. PubMed ID: 17157792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.
    Staaf J; Jönsson G; Ringnér M; Vallon-Christersson J; Grabau D; Arason A; Gunnarsson H; Agnarsson BA; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
    Breast Cancer Res; 2010; 12(3):R25. PubMed ID: 20459607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
    Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
    Elife; 2020 May; 9():. PubMed ID: 32401198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.
    Dressman MA; Baras A; Malinowski R; Alvis LB; Kwon I; Walz TM; Polymeropoulos MH
    Cancer Res; 2003 May; 63(9):2194-9. PubMed ID: 12727839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
    Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
    Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
    Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
    Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
    Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.
    Isola JJ; Kallioniemi OP; Chu LW; Fuqua SA; Hilsenbeck SG; Osborne CK; Waldman FM
    Am J Pathol; 1995 Oct; 147(4):905-11. PubMed ID: 7573366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.
    Pollack JR; Sørlie T; Perou CM; Rees CA; Jeffrey SS; Lonning PE; Tibshirani R; Botstein D; Børresen-Dale AL; Brown PO
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12963-8. PubMed ID: 12297621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
    Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F
    Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
    Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
    Naylor TL; Greshock J; Wang Y; Colligon T; Yu QC; Clemmer V; Zaks TZ; Weber BL
    Breast Cancer Res; 2005; 7(6):R1186-98. PubMed ID: 16457699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
    Rennstam K; Ahlstedt-Soini M; Baldetorp B; Bendahl PO; Borg A; Karhu R; Tanner M; Tirkkonen M; Isola J
    Cancer Res; 2003 Dec; 63(24):8861-8. PubMed ID: 14695203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
    Järvinen TA; Tanner M; Bärlund M; Borg A; Isola J
    Genes Chromosomes Cancer; 1999 Oct; 26(2):142-50. PubMed ID: 10469452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
    Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
    Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma.
    Parris TZ; Danielsson A; Nemes S; Kovács A; Delle U; Fallenius G; Möllerström E; Karlsson P; Helou K
    Clin Cancer Res; 2010 Aug; 16(15):3860-74. PubMed ID: 20551037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
    Savinainen KJ; Saramäki OR; Linja MJ; Bratt O; Tammela TL; Isola JJ; Visakorpi T
    Am J Pathol; 2002 Jan; 160(1):339-45. PubMed ID: 11786427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
    Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
    Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene copy mapping of the ERBB2/TOP2A region in breast cancer.
    Jacobson KK; Morrison LE; Henderson BT; Blondin BA; Wilber KA; Legator MS; O'Hare A; Van Stedum SC; Proffitt JH; Seelig SA; Coon JS
    Genes Chromosomes Cancer; 2004 May; 40(1):19-31. PubMed ID: 15034864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.